Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis

18 Apr 2020

Abstract excerpt

OBJECTIVE: Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple sclerosis. As with other MS treatments, this is often interpreted as 'pseudoatrophy', related to reduced inflammation. Treatment-related neurotoxicity may be contributory. We sought objective evidence of post-IAHSCT toxicity by quantifying levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related cognitive impairment studies
Share to Hematopoietic Stem Cell Transplantation
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32304358
DOI: 10.1002/acn3.51045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosisPMID 32304358Read ↗

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read ↗

Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosisSemantic proximity Read ↗

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell TransplantSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisSemantic proximity Read ↗

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisSemantic proximity Read ↗

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.Semantic proximity Read ↗

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisSemantic proximity Read ↗

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantationSemantic proximity Read ↗

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosisSemantic proximity Read ↗

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple SclerosisSemantic proximity Read ↗

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.